Improving surgical outcomes: standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary lymph node dissection

Francis, Wesley; Abghari, Pamella; Du, Wei; Rymal, Christine; Suna, Moheen; Kosir, Mary A.

doi:10.1016/j.amjsurg.2006.08.018

Cited by 62 publications

(39 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…That said, the hypothesis that SLNB completely eliminates lymphedema risk has not been supported. One study found 17% of women with SLNB alone (no follow-up axillary dissections) developed grade 1 or higher lymphedema (11). In addition to lymph node removal and trauma to the lymph system resultant to surgery, there is evidence that risk of lymphedema may be increased by as much as 48% among women who undergo radiotherapy compared to those who do not receive radiotherapy (18).…”

Section: Curative Treatments and Breast Cancer Related Lymphedemamentioning

confidence: 99%

Balancing Lymphedema Risk

Schmitz

2010

Exercise and Sport Sciences Reviews

View full text Add to dashboard Cite

show abstract

Section: Curative Treatments and Breast Cancer Related Lymphedemamentioning

confidence: 99%

Balancing Lymphedema Risk

Schmitz

2010

Exercise and Sport Sciences Reviews

View full text Add to dashboard Cite

show abstract

“…All breast cancer patients who undergo surgical treatment in the axilla (axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB)) are at risk for the development of breast cancer related lymphedema (BCRL). The incidence of BCRL varies in the literature from 7% to 30% depending on the definition of BCRL used, the type of surgery performed and the length of follow-up [2-4]. …”

Section: Introductionmentioning

confidence: 99%

Lifestyle Risk Factors Associated with Arm Swelling Among Women with Breast Cancer

et al. 2012

View full text Add to dashboard Cite

Background Breast cancer-related lymphedema (BCRL) is a feared complication for breast cancer patients who have undergone axillary surgery. Although clinical risk factors for BCRL are defined; data are sparse regarding common exposures that might induce incident arm swelling. The goal of this study was to quantify the association between common exposures thought to be potential risk factors, and the occurrence of incident arm swelling, among breast cancer survivors with or at-risk for BCRL. Methods This is a prospective sub-analysis of the PAL trial, a randomized controlled trial of 295 breast cancer survivors. Participants reported their exposure to 30 different potential risk-factors at three month intervals for one year. Incident arm swelling was defined as a ≥5% increase in inter-limb water volume difference between two consecutive time points. Results Twenty-seven participants (9%) experienced incident arm swelling and 268 patients (91%) did not. Sauna use was the only exposure that was significantly predictive of incident arm swelling (p=0.05). Non-White and non-Black participants had a significantly increased risk for experiencing incident arm swelling (p=0.005) for both comparisons. Conclusions In our patient cohort, many common exposures that have been reported to be risk factors did not prove to have a significant predictive relationship for incident arm swelling. This study supports the recommendation that breast cancer patients who have had axillary surgery should avoid sauna use. The results do not confirm the need for other restrictions that may interfere with the quality of life in women with breast cancer.

show abstract

“…Further research is necessary as currently inter-study comparison of assessment or management programs are confounded by the absence of a universally agreed definition. 33 An historical review of BCRL literature suggested that advances in management and detection may have created temporal variations in breast cancer populations with respect to BCRL incidence. 15 The population of breast cancer survivors currently alive includes those treated with radical, and later, modified radical mastectomy, breast conserving surgery, various levels of axillary dissection, radiotherapy using a multitude of protocols, as well as numerous chemo-therapy and hormone therapy regimens.…”

Section: Breast Cancer-related Lymphoedemamentioning

confidence: 99%

Breast cancer-related lymphoedema risk reduction advice: A challenge for health professionals

Nielsen

Gordon

Selby

2008

Cancer Treatment Reviews

View full text Add to dashboard Cite

SummaryBreast cancer-related lymphoedema (BCRL) is a debilitating, distressing condition affecting approximately one in five breast cancer survivors (Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM 2005;98:343-8). The evidence-base for breast cancer-related lymphoedema risk reduction advice is scant and contradictory, with most studies in the area limited by small numbers, retrospective design and other methodological inadequacies. Current advice has the capacity to profoundly alter quality of life following treatment for breast cancer. Health professionals should review the risk reduction advice they provide to reflect the current understanding of aetiology and risk factors. Further research is required to provide more evidence for the content, to identify optimal methods of precautionary education delivery and to determine the effect of the advice on the patient's quality of life and perception of recovery.

show abstract

Improving surgical outcomes: standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary lymph node dissection

Cited by 62 publications

References 12 publications

Balancing Lymphedema Risk

Balancing Lymphedema Risk

Lifestyle Risk Factors Associated with Arm Swelling Among Women with Breast Cancer

Breast cancer-related lymphoedema risk reduction advice: A challenge for health professionals

Contact Info

Product

Resources

About